
Healthcare & Pharmaceuticals · BSE
Asston Pharmaceuticals Limited, established in 2019, is a pharmaceutical company focused on exporting healthcare products worldwide. It offers a wide range of products, including tablets, capsules, sachets, and syrups. These cover various therapeutic areas such as pain relief, antibiotics, antifungals, vitamins, and more. The company manufactures medicines for its own sales as well as on a contract basis, mainly working directly with different marketers. It holds certifications from both Central and State FDA, along with NQA accreditation, and follows Quality Management System standards to maintain product quality. As of July 3, 2025, the company employs 46 permanent staff and 6 contractual workers across different departments.
Price Band
₹115 – ₹123
Issue Size
₹27.56 Cr
Lot Size
1000 shares
GMP
+21.1%
Est. Listing
₹149
at current GMP
Subscribed
186.59x
overall
Open
9 Jul 2025
Close
11 Jul 2025
Allotment
14 Jul 2025
Refund
15 Jul 2025
Demat Credit
16 Jul 2025
Listing
16 Jul 2025
Overall Subscription
186.59x
Total Demand
QIB Multiplier
85.76x
Institutions & Funds
NII / HNI
353.15x
High Net-Worth
Retail (RII)
172.14x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 425,000 | 36,449,000 | 85.76x |
| NIB | 322,000 | 113,713,000 | 353.15x |
| HNIs(10L +) | 215,000 | 91,149,000 | 423.95x |
| HNIs (2-10L) | 108,000 | 22,564,000 | 208.93x |
| RETAIL | 746,000 | 128,416,000 | 172.14x |
| Total | 1,816,000 | 392,291,000 | 186.59x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| RETAIL | 373 | 64,208 | 172.14x |
| HNIs(10L +) | 72 | 8,616 | 119.67x |
| HNIs (2-10L) | 36 | 6,457 | 179.36x |
| Total Applications | 481 | 79,281 | 164.83x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Asston Pharmaceuticals Limited is bringing an initial public offering (IPO) in the Healthcare & Pharmaceuticals sector with an aggregate issue size of ₹27.56 Crores. The shares are offered at a price band of ₹115 to ₹123 per equity share on BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2025-07-11, the basis of allotment is scheduled to be finalized on 2025-07-14. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Maashitla Securities Private Limited) or the BSE allotment checking window.
The latest Grey Market Premium (GMP) for Asston Pharmaceuticals Limited IPO is ₹26 per equity share. Based on the upper price band of ₹115 to ₹123 per equity share, the estimated listing price is ₹149 (+21.1% expected listing gain).
With a lot size of 1000 shares and current GMP of ₹26, the expected profit per application lot is approx ₹26,000 (+21.1% gain). Minimum application cost is approx ₹1,23,000.
The Asston Pharmaceuticals Limited IPO aggregate issue size is ₹27.56 Crores with an equity price band set at ₹115 to ₹123 per equity share. The retail lot size is 1000 shares requiring a minimum capital outlay of approx. ₹1,23,000.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 186.59x (Retail: 172.14x, QIB: 85.76x, NII: 353.15x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Maashitla Securities Private Limited) and the BSE status verification website on or around 2025-07-14. Investors can verify status using PAN card or application number.
Asston Pharmaceuticals Limited shares are scheduled to list on BSE on 2025-07-16.